The highest rate of BRAF mutation was observed in non-chronic sun-induced damage melanoma but almost all histological subtypes of melanoma may exhibit such mutation making it an attractive candidate for targeted therapy at advanced or metastatic stages [7], [16]. The gene discussed is BRAF; the disease is melanoma.